Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma - Viardot, Andreas; Nagorsen, Dirk (Blood, 2016)
Gesehen am 31.10.2019